Hughes Financial Services’s Neuropace NPCE Stock Holding History

Hughes Financial Services’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143	Buy	9 +4	+80%	+$64	﹤0.01%	1361
2026 Q1	$66	Sell	5 -9	-64%	-$135	﹤0.01%	1395
2025 Q4	$216	Buy	+14	New	+$187	﹤0.01%	988

Other funds holding NPCE

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Hughes Financial Services's NPCE Position: Q2 2026 in Review

Hughes Financial Services increased its Neuropace (NPCE) stake by 80% in Q2 2026, buying an estimated $64 and bringing the position to 9 shares worth $143. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

Hughes Financial Services first reported a position in NPCE in Q4 2025 and has held it in 3 quarters since. The position peaked at $216 in Q4 2025. 4 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

Hughes Financial Services held 9 shares of Neuropace worth $143 as of Q2 2026.
Hughes Financial Services bought 4 Neuropace shares in Q2 2026, an estimated $64.
Neuropace made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1361 holding.
Hughes Financial Services first reported a position in Neuropace in Q4 2025 and has held it in 3 quarters since.
Hughes Financial Services's Neuropace position peaked at $216 in Q4 2025.
4 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.